Stephen Lyle to Neoplasm Grading
This is a "connection" page, showing publications Stephen Lyle has written about Neoplasm Grading.
Connection Strength
0.094
-
Bremer T, Whitworth PW, Patel R, Savala J, Barry T, Lyle S, Leesman G, Linke SP, Jirstr?m K, Zhou W, Amini RM, W?rnberg F. A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk. Clin Cancer Res. 2018 12 01; 24(23):5895-5901.
Score: 0.035
-
Okamoto T, Takada K, Sato S, Toyokawa G, Tagawa T, Shoji F, Nakanishi R, Oki E, Koike T, Nagahashi M, Ichikawa H, Shimada Y, Watanabe S, Kikuchi T, Akazawa K, Lyle S, Takabe K, Okuda S, Sugio K, Wakai T, Tsuchida M, Maehara Y. Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung. Ann Surg Oncol. 2018 Jun; 25(6):1564-1571.
Score: 0.034
-
Druliner BR, Fincher JA, Sexton BS, Vera DL, Roche M, Lyle S, Dennis JH. Chromatin patterns associated with lung adenocarcinoma progression. Cell Cycle. 2013 May 15; 12(10):1536-43.
Score: 0.024